Persistent severe acute respiratory distress syndrome for the prognostic enrichment of trials.
<h4>Background</h4>Acute respiratory distress syndrome (ARDS) is heterogeneous. As an indication of the heterogeneity of ARDS, there are patients whose syndrome improves rapidly (i.e., within 24 hours), others whose hypoxemia improves gradually and still others whose severe hypoxemia per...
Main Authors: | Elizabeth Sanchez, David R Price, Kuei-Pin Chung, Clara Oromendia, Augustine M K Choi, Edward J Schenck, Ilias I Siempos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0227346 |
Similar Items
-
Prognostic factors in the acute respiratory distress syndrome
by: Wei Chen, et al.
Published: (2015-12-01) -
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
by: Jinkyeong Park, et al.
Published: (2017-12-01) -
Hereditary mucoepithelial dysplasia and severe respiratory distress
by: Mahmoud Halawa, et al.
Published: (2015-01-01) -
Intrathoracic lipoblastoma presenting with severe respiratory distress
by: Joseph Motshedi Sekgololo, et al.
Published: (2017-12-01) -
Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
by: Pneumatikos Ioannis, et al.
Published: (2005-06-01)